Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Anthony Kirabira
Observed name:
A. Kirabira
Institutions:
Malaria Consortium,
Malaria Consortium,
Makerere University
Observed institutions:
Malaria Consortium,
Malaria Consortium,
Baylor College of Medicine Children’s Foundation,
Joint Clinical Research Centre,
Makerere University
ORCID:
0009-0001-8528-8570
Observed ORCID:
0009-0001-8528-8570
OpenAlex ID:
A5113392054
Once-daily dolutegravir-based antiretroviral therapy in infants and children living with HIV from age 4 weeks: results from the below 14 kg cohort in the randomised ODYSSEY trial
2022
·
Pauline Amuge
, Abbas Lugemwa
, et al.
·
The Lancet HIV
·
38
PDF
Dolutegravir twice-daily dosing in children with HIV-associated tuberculosis: a pharmacokinetic and safety study within the open-label, multicentre, randomised, non-inferiority ODYSSEY trial
2022
·
Anna Turkova
, Hylke Waalewijn
, et al.
·
The Lancet HIV
·
25
PDF
Nucleoside/nucleotide reverse transcriptase inhibitor sparing regimen with once daily integrase inhibitor plus boosted darunavir is non-inferior to standard of care in virologically-suppressed children and adolescents living with HIV – Week 48 results of the randomised SMILE Penta-17-ANRS 152 clinical trial
2023
·
Alexandra Compagnucci
, Man K. Chan
, et al.
·
EClinicalMedicine
·
18
PDF
Neuropsychiatric manifestations and sleep disturbances with dolutegravir-based antiretroviral therapy versus standard of care in children and adolescents: a secondary analysis of the ODYSSEY trial
2023
·
Anna Turkova
, Ellen White
, et al.
·
The Lancet Child & Adolescent Health
·
14
PDF
Changes in serum concentration of perioperative inflammatory cytokines following the timing of surgery among mild–moderate traumatic brain injury patients and factors associated
2024
·
Hervé Monka Lekuya
, Stephen Cose
, et al.
·
Frontiers in Neurology
·
5
PDF
Weight gain, body composition, and metabolic parameters of dolutegravir-based antiretroviral therapy versus standard of care in children and adolescents: an ancillary analysis of the ODYSSEY trial
2026
·
Anna Turkova
, Ellen White
, et al.
·
The Lancet Child & Adolescent Health
·
4
Timing of Surgery and Preoperative Predictors of Surgical Site Infections for Patients with Depressed Skull Fractures in a Sub-Saharan Tertiary Hospital: A Prospective Cohort Study
2024
·
Hervé Monka Lekuya
, Jelle Vandersteene
, et al.
·
Neurotrauma Reports
·
4
PDF
Once-daily dolutegravir/lamivudine fixed-dose formulations in children living with HIV: a pharmacokinetic and safety sub-study nested in the open-label, multicentre, randomised, non-inferiority D3/PENTA 21 trial
2025
·
Lisanne A.H. Bevers
, Gabriela Toledo
, et al.
·
EBioMedicine
·
3
Efficacy and safety of short-cycle, dolutegravir-based antiretroviral therapy in adolescents living with HIV (BREATHER Plus): a multicentre, open-label, randomised, parallel, two-arm, non-inferiority trial
2026
·
Adeodata R Kekitiinwa
, Angus Jennings
, et al.
·
The Lancet HIV
·
2
Trial design and enrolment characteristics of LATA (Long-Acting Treatment in Adolescents): A randomised, open-label, non-inferiority, 96-week trial evaluating the virological efficacy, safety, acceptability and quality-of-life of the dual long-acting injectable regimen cabotegravir/ rilpivirine compared to daily oral therapy in virologically suppressed adolescents with HIV-1 infection, aged 12 to <20 years, in Sub-Saharan Africa
2026
·
Diana Anena
, Elizabeth Chappell
, et al.
·
Contemporary Clinical Trials
·
2
Switch to injectable cabotegravir–rilpivirine given every 8 weeks in adolescents living with HIV with virological suppression in sub-Saharan Africa (LATA): a randomised, open-label, multicentre, 96-week non-inferiority trial
2026
·
Mutsa Bwakura-Dangarembizi
, Elizabeth Chappell
, et al.
·
The Lancet
·
1
Trends and factors associated with retention in HIV care among men living with HIV in a peri-urban primary care facility in central Uganda: a retrospective cohort study
2025
·
Victoria Babirye Tumusiime
, Joan Nangendo
, et al.
·
BMC Public Health
·
1
PDF
Predictors of Viral Rebound Among Adolescents at an Urban Clinic in Kampala Using Repeated Events Survival Analysis
2024
·
Anthony Kirabira
, Justine Bukenya
, et al.
·
medRxiv
·
1
PDF
Correction: Cohort retention in seasonal malaria chemoprevention: an analysis of magnitude and associated factors in Northern Bahr el Ghazal, South Sudan
2026
·
Francis Okot
, Norman Aweno
, et al.
·
Frontiers in Malaria
PDF
Cohort retention in seasonal malaria chemoprevention: an analysis of magnitude and associated factors in Northern Bahr el Ghazal, South Sudan
2026
·
Francis Okot
, Norman Aweno
, et al.
·
Frontiers in Malaria
PDF
Predictors of tobacco smoking among youth in an urban slum in Kampala, Uganda: A cross-sectional study
2026
·
Joyce Nakitende
, Anthony Kirabira
, et al.
·
PLoS ONE
Tobacco use patterns and associated factors among youth in Kampala’s informal settlements: a cross-sectional study in Bwaise
2025
·
Nakitende Joyce
, Anthony Kirabira
, et al.
·
BMC Public Health
PDF
Show more works
View as search
Works count:
17
Citation count:
118
H-index:
5
I10-index:
4
Year
Topic
Type